These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6471583)

  • 21. Clinical and radiological features of bone disease in long-term (15 or more years) hemodialysis patients.
    Bedani PL; Orzincolo C; Storari A; Perini L; Soffritti S; Gilli P
    Int J Artif Organs; 1993 Oct; 16(10):704-10. PubMed ID: 8125616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled trial of calcitriol in the prevention of bone disease in haemodialysed patients.
    Sharman VL; Abrams SM; Adami S; Cattell WR; Chaput de Saintonge DM; Greenwood RN; Goodwin FJ; Hately W; Hattersley LA; Marsh FP; Morgan AG; Muir JW; O'Riordan JL; Papapoulos SE; Revell P; Tucker AK; Baker LR
    Proc Eur Dial Transplant Assoc; 1983; 19():287-92. PubMed ID: 6348740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
    Di Landro D; Zanatta GP; Simioni N; Pinzani A; Zotti D; Perin N; Bertoli M; Naso A; Ruffatti A; Gasparotto ML
    Minerva Med; 1985 Mar; 76(9-10):419-23. PubMed ID: 3982699
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of renal osteodystrophy in patients dialyzed with deionized and non-deionized water.
    Posen GA; Gray DG; Jaworski ZF; Couture R; Rashid A
    Trans Am Soc Artif Intern Organs; 1972; 18(0):405-11. PubMed ID: 4610968
    [No Abstract]   [Full Text] [Related]  

  • 26. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G; Bianchi ML; Valenti G
    Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vitamin A status of patients with chronic renal failure in relation to renal osteodystrophy].
    Stein G; Abendroth K; Kokot F; Keil E; Schöne S; Wessel G; Fünfstück R; Sperschneider H
    Z Urol Nephrol; 1985 Mar; 78(3):159-65. PubMed ID: 4002896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydrotachysterol treatment in renal osteodystrophy; the effect on alkaline and acid phosphatase.
    Van Kesteren RG; Duursma SA; Dorhout Mees EJ
    Neth J Med; 1978; 21(1):17-22. PubMed ID: 634412
    [No Abstract]   [Full Text] [Related]  

  • 29. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E
    J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal osteodystrophy.
    Coburn JW; Henry DA
    Adv Intern Med; 1984; 30():387-424. PubMed ID: 6397042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on calcium-regulating hormone in patients on chronic hemodialysis with special reference to renal osteodystrophy (ROD) (author's transl)].
    Kudo S
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):181-96. PubMed ID: 7098141
    [No Abstract]   [Full Text] [Related]  

  • 32. The evolution of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Calderaro V; Oreopoulos DG; Meema HE; Ogilvie R; Husdan H; Khanna R; Quinton C; Murray T; Carmichael D
    Proc Eur Dial Transplant Assoc; 1980; 17():533-42. PubMed ID: 6787584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal osteodystrophy in Maracaibo].
    Salgado O; García R; Delling G; Navarro J; Romero RA; Rodríguez-Iturbe B
    Invest Clin; 1992; 33(4):153-64. PubMed ID: 1303675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal osteodystrophy: the importance of 1-alpha-OH-D3].
    Berland Y; Olmer M; Grandvuillemin M; Lachaize AM
    Sem Hop; 1981 Mar 8-15; 57(9-10):445-9. PubMed ID: 6261385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma hydroxyproline in renal osteodystrophy.
    Varghese Z; Moorhead JF; Tatler GL; Baillod RA; Wills MR
    Proc Eur Dial Transplant Assoc; 1973; 10(0):187-96. PubMed ID: 4802560
    [No Abstract]   [Full Text] [Related]  

  • 36. [Aluminum in renal osteodystrophy].
    Zhu P; Wang GY; Yu YF; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):176-8. PubMed ID: 8222983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renal osteodystrophy in patients under intermittent hemodialysis treatment at the Linköping regional hospital].
    Lundberg M
    Lakartidningen; 1980 Jun; 77(26-27):2423-5. PubMed ID: 7401790
    [No Abstract]   [Full Text] [Related]  

  • 38. Prediction of radiographic severity of renal osteodystrophy by serum values.
    Guerra LE; Amato JA; Galen MA; Maher JF
    Int Urol Nephrol; 1980; 12(1):65-72. PubMed ID: 7239840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Teaching program effects on high phosphorus levels in patients receiving hemodialysis.
    Schlatter S; Ferrans CE
    ANNA J; 1998 Feb; 25(1):31-6; discussion 37-8. PubMed ID: 9543905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term treatment of renalosteodystrophy with 1 alpha-hydroxycholecalciferol].
    Marco Franco JE; Alarcón Zurita A; Pizá Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S; Dalmau Diana M
    Rev Clin Esp; 1982 Jan; 164(1):33-5. PubMed ID: 7071401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.